Trial intelligence / Profile preview

Effect of Trypan Blue on Corneal Endothelial Cell Count During Phacoemulsification

NCT07735000Completed

Sponsor
Hayatabad Medical Complex
Start
Mar 2024
Primary completion
Sep 2024
Countries
1
01

Overview

Randomised trial of trypan blue in cataract (2 arms), sponsored by Hayatabad Medical Complex. Primary endpoint: Postoperative Corneal Endothelial Cell Count at 4 weeks. Started Mar 2024; status: completed.

02

Drugs

trypan blue
03

Conditions

cataract

Beyond the preview

Go deeper on NCT07735000.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07735000.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call